Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Aβ oligomerization
Open Access
- 1 July 2004
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 18 (12) , 1366-1372
- https://doi.org/10.1096/fj.04-1764com
Abstract
In the past two decades, a large body of evidence has established a causative role for the β-amy-loid peptide (Aβ) in Alzheimer's disease (AD). However, recent debate has focused on whether amyloid f...Keywords
Funding Information
- John Simon Guggenheim Memorial Foundation
- Financiadora de Estudos e Projetos
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
This publication has 42 references indexed in Scilit:
- Aβ Aggregation inhibitors. Part 1: Synthesis and biological activity of phenylazo benzenesulfonamidesBioorganic & Medicinal Chemistry Letters, 2004
- Therapeutic approaches to protein-misfolding diseasesNature, 2003
- Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of PathogenesisScience, 2003
- Alzheimer's Disease Is a Synaptic FailureScience, 2002
- Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease modelNature Neuroscience, 2002
- Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivoNature, 2002
- Inhibition of Alzheimer's disease β‐amyloid aggregation, neurotoxicity, and in vivo deposition by nitrophenols: implications for Alzheimer's therapyThe FASEB Journal, 2001
- Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's DiseaseThe American Journal of Pathology, 1999
- Enhanced Production and Oligomerization of the 42-residue Amyloid β-Protein by Chinese Hamster Ovary Cells Stably Expressing Mutant PresenilinsJournal of Biological Chemistry, 1997
- Correlations of synaptic and pathological markers with cognition of the elderlyNeurobiology of Aging, 1995